ClinicalTrials.gg
Not yet recruitingNCT07819201Taabo T3Updated Sep 17, 2026

Improving Maternal and Neonatal Care-seeking Through a Video-informed Training Session During the Third Trimester of Pregnancy

An interventional study of Information video and planning session in Maternal Health, Neonatal Health and Pregnancy, sponsored by Swiss Tropical & Public Health Institute. Not yet recruiting at 1 site in Côte d’Ivoire. Open to female participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Swiss Tropical & Public Health Institute · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
800
Allocation
Randomized
Ages
15 Years and older
Sex
Female
01

Study summary

This study is a randomized controlled trial evaluating the impact of a video-informed training session on maternal and newborn health care seeking in rural Côte d'Ivoire.

Read the detailed description

In Taabo, Côte d'Ivoire, many women do not receive recommended care during the third trimester of pregnancy or the early postpartum period, contributing to adverse maternal and neonatal health outcomes. In this individual-level open-label randomized controlled trial, we will evaluate the impact of an information and planning intervention on timely care-seeking during the third trimester of pregnancy and the early postpartum period. The study will enroll 800 women who are currently in the third trimester of pregnancy and randomize them to one of two groups: (1) control, or (2) information video and planning session for the pregnant women and her partner. A baseline survey will be performed at the time of enrollment, and outcomes will be evaluated using an endline survey 6-8 weeks after the end of pregnancy. The main outcome of the study is the number of health care contacts that women have between enrollment in the study and 6 weeks postpartum.

02

Conditions studied

  • Maternal Health
  • Neonatal Health
  • Pregnancy
  • Postpartum Care

Browse trials for

Keywords

  • Pregnancy
  • Maternal health
  • Stillbirth
  • Postpartum
  • Antenatal
  • Côte d'Ivoire
  • west Africa
  • Information intervention
03

In context

Stillbirth

121 studies on the registry are indexed under Stillbirth; 34 are open to participants now.

This study's planned enrollment of 800 is above the median of 476 across 65 interventional studies indexed under Stillbirth.

Browse Stillbirth studies →

Lead sponsor

Swiss Tropical & Public Health Institute is the lead sponsor of 58 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for Pregnant Women:

  • Currently pregnant
  • Aged 15 years or older
  • Live in the area served by the Taabo Health \& Demographic Surveillance System
  • Estimated gestational age between 6 completed months of pregnancy and 8 completed months of pregnancy

Inclusion Criteria for Male Partners:

  • Aged 15 or older
  • Married to or currently the main romantic partner of a woman who is enrolled in the study
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
800 participants (estimated)

Study arms

  • No intervention
    Control group

    This group will not receive any intervention.

  • Experimental
    Information Video and Planning Session group

    This group will receive the study intervention, including an information video and planning session for the pregnant woman and her partner.

    Other: Information video and planning session

Interventions

  • OtherInformation video and planning session

    The study intervention is a video-informed information and planning session for health care during the third trimester, childbirth, and the first six weeks postpartum. In this intervention, a member of the study team will show information videos to pregnant women and her partner, summarizing key recommendations for health and health care seeking during the third trimester of pregnancy and the first six weeks following childbirth. After showing the videos, the study team member will guide the pregnant woman and her partner in a short discussion about planning for care-seeking during the third trimester and early postpartum period. This discussion will include quizzing on the content of the information videos and discussions of care-seeking plans together with the couple.

06

What researchers measure

Primary outcomes

  1. Number of health care contacts as reported by women during endline survey

    Number of health care contacts that women have between enrollment in the study and 6 weeks postpartum, including antenatal care visits, childbirth, and postpartum care visits

    Time frame: From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)

Secondary outcomes

  1. Number of antenatal care visits as reported by women during endline survey

    Number of antenatal care visits

    Time frame: Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)

  2. Facility-based childbirth as reported by women during endline survey

    Proportion of women who gave birth in a health facility

    Time frame: Measured 6-8 weeks after the end of pregnancy

  3. Number of postpartum visits as reported by women during endline survey

    Number of postpartum care visits between the end of pregnancy and 6 weeks postpartum

    Time frame: From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)

  4. Average care-seeking knowledge scores among pregnant women and their partners

    Average scores (among pregnant women and their partners) on assessments of knowledge of care-seeking recommendations during the third trimester and the early postpartum period, as measured using five questions during endline surveys with pregnant women and their partners. We create a Care-Seeking Knowledge Scale as follows: Participants receive 1 point if they respond with 3 or more when asked how many postpartum visits women should have during the first 6 weeks after childbirth; 1 point if they correctly name at least 3 danger signs for women during pregnancy; 1 point if they correctly name at least 3 danger signs for women during the first six weeks after childbirth; and 1 point if they correctly name at least 3 danger signs for newborns. Scores range from 0 to 4 with higher scores representing greater knowledge.

    Time frame: Measured 6-8 weeks after the end of pregnancy

  5. Fetal movement counting as reported by women during endline surveys

    The proportion of pregnant women who report counting fetal movements at least once during the final month of their pregnancy

    Time frame: Measured 6-8 weeks after the end of pregnancy

  6. Perinatal mortality as reported by women during endline surveys

    The proportion of women who experience a stillbirth or neonatal death in the first seven days of life (perinatal mortality)

    Time frame: Measured 6-8 weeks after end of pregnancy

  7. Neonatal mortality as reported by women during endline surveys

    The proportion of women whose child dies in the first 28 days of life

    Time frame: Measured 6-8 weeks after end of pregnancy

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — De-identified data files and analytic code will be posted on public repositories at the time of publication of results.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: We plan to share IPD and supporting information at the time of publication.

Access criteria: IPD and supporting information will be made available on public repositories.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for May 2027, 8 months later.

Of 25 interventional studies with no phase under Stillbirth, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 31. This study's planned 8 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 8, 2026
First posted
Sep 14, 2026
StartEst.
Sep 2026
Primary completionEst.
May 2027
CompletionEst.
May 2027
Last update
Sep 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07819201
Lead sponsor
Swiss Tropical & Public Health Institute
Collaborators
Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
Responsible party
Sponsor
First posted
Sep 14, 2026
Start date
Sep 2026 (estimated)
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Sep 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion